Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

Alzheimer s Research & Therapy ◽

10.1186/alzrt146 ◽

2012 ◽

Vol 4 (5) ◽

pp. 43 ◽

Author(s):

John M Ringman ◽

Sally A Frautschy ◽

Edmond Teng ◽

Aynun N Begum ◽

Jenny Bardens ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1124846.581937 ◽

2008 ◽

Author(s):

Elio Scarpini ◽

Daniela Galimberti

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Activities Of Daily Living ◽

Daily Living ◽

Controlled Study ◽

Double Blind ◽

Global Function ◽

Double Blind Placebo

Download Full-text

Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study

BMC Medical Genetics ◽

10.1186/1471-2350-12-137 ◽

2011 ◽

Vol 12 (1) ◽

Author(s):

Samuel T Henderson ◽

Judes Poirier

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Ketone Body ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled study

Neurology ◽

10.1212/01.wnl.0000052994.54660.58 ◽

2003 ◽

Vol 60 (7) ◽

pp. 1071-1076 ◽

Author(s):

O.M. Wolkowitz ◽

J.H. Kramer ◽

V.I. Reus ◽

M.M. Costa ◽

K. Yaffe ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group

Archives of Internal Medicine ◽

10.1001/archinte.155.16.1766 ◽

1995 ◽

Vol 155 (16) ◽

pp. 1766-1772 ◽

Author(s):

P. G. Antuono

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Study ◽

Study Group ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting

Journal of the American Geriatrics Society ◽

10.1111/j.1532-5415.2001.49266.x ◽

2001 ◽

Vol 49 (12) ◽

pp. 1590-1599 ◽

Author(s):

Pierre N. Tariot ◽

Jeffrey L. Cummings ◽

Ira R. Katz ◽

Jacobo Mintzer ◽

Carlos A. Perdomo ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Nursing Home ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Home Setting ◽

Double Blind Placebo ◽

Nursing Home Setting

Download Full-text

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study

Progress in Neuro-Psychopharmacology and Biological Psychiatry ◽

10.1016/j.pnpbp.2008.05.015 ◽

2008 ◽

Vol 32 (6) ◽

pp. 1538-1544 ◽

Author(s):

Chih-Chiang Chiu ◽

Kuan-Pin Su ◽

Tsung-Chi Cheng ◽

Hsing-Cheng Liu ◽

Ching-Jui Chang ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Fatty Acids ◽

Cognitive Impairment ◽

Mild Cognitive Impairment ◽

Controlled Study ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

10.1016/s0140-6736(01)05623-9 ◽

2001 ◽

Vol 358 (9280) ◽

pp. 455-460 ◽

Author(s):

Willem A Van Gool ◽

Henry C Weinstein ◽

Philip K Scheltens ◽

Gerard JM Walstra

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Early Alzheimer’S Disease

Download Full-text

P4-337: Dimebon improves cognition, function, and behavior in mild and moderate Alzheimer's disease: Results by severity of a one-year, double-blind, placebo-controlled study

Alzheimer s & Dementia ◽

10.1016/j.jalz.2008.05.2407 ◽

2008 ◽

Vol 4 ◽

pp. T771-T771

Author(s):

Rachelle S. Doody ◽

Svetlana Gavrilova ◽

Ronald Thomas ◽

Paul Aisen ◽

Sergey Bachurin ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

One Year ◽

Download Full-text

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

10.1016/s0140-6736(08)61074-0 ◽

2008 ◽

Vol 372 (9634) ◽

pp. 207-215 ◽

Author(s):

Rachelle S Doody ◽

Svetlana I Gavrilova ◽

Mary Sano ◽

Ronald G Thomas ◽

Paul S Aisen ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Activities Of Daily Living ◽

Daily Living ◽

Controlled Study ◽

Double Blind ◽

Global Function ◽

Double Blind Placebo

Download Full-text

P2-402: Double-blind, placebo-controlled study of three different dosages of cerebrolysin in patients with mild to moderate Alzheimer's disease

Alzheimer s & Dementia ◽

10.1016/j.jalz.2006.05.1243 ◽

2006 ◽

Vol 2 ◽

pp. S364-S364 ◽

Author(s):

Anton Alvarez ◽

Marta Laredo ◽

Miguel Varela ◽

Ramon Cacabelos ◽

Carolina Sanpedro ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text